THYMOMA AND THYMIC CARCINOMA
Clinical trials for THYMOMA AND THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYMOMA AND THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYMOMA AND THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy combo targets rare cancers left behind by progress
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs, domvanalimab and zimberelimab, in people with five types of advanced rare cancers (peritoneal mesothelioma, gestational trophoblastic tumor, anaplastic thyroid carcinoma, neuroendocrine tumors, and thymic carcinom…
Matched conditions: THYMOMA AND THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Thymoma treatment trial pulled before starting
Knowledge-focused TerminatedThis study was designed to see if adding chemotherapy to radiation therapy after incomplete surgery for thymoma or thymic carcinoma could improve survival. It planned to enroll adults aged 18-75 who had incomplete tumor removal. However, the trial was withdrawn before any partici…
Matched conditions: THYMOMA AND THYMIC CARCINOMA
Phase: PHASE3 • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC